Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS National Pharmaceuticals Generic Products - Wave 15b
Offer reference number: CM/PHG/23/5698
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/23/5698/01 - Orals (plus non-parenteral) Products
CESW: (Midlands and Southwest): 1st October 2025 to 31st May 2027 (20 months)
NWLN: (Northwest and London North): 1st October 2025 to 31st May 2027 (20 months)
LSNE: (London South and Northeast): 1st October 2025 to 31st May 2027 (20 months)
CM/PHG/23/5698/02 - Hospital Only Products
DCE (Midlands) & DSW (Southwest): 1st October 2025 to 30th September 2027 (24 months)
CM/PHG/23/5698/03 - Hospital Only (Housekeeping) Products
DLS (London South) & DNE (Northeast): 1st October 2025 to 31st May 2026 (8 months)
DNW (Northwest) & DLN (London North): 1st October 2025 to 31st January 2027 (16 months)
DCE (Midlands) & DSW (Southwest): 1st October 2025 to 31st May 2026 (8 months)
Additional information:
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: …@atamis.co.uk
No supplier information available.